These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14687900)

  • 1. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2004 Jan; 339(1-2):105-15. PubMed ID: 14687900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
    Deepa PR; Varalakshmi P
    Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences.
    Deepa PR; Varalakshmi P
    Mol Cell Biochem; 2003 Dec; 254(1-2):111-6. PubMed ID: 14674688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity.
    Deepa PR; Varalakshmi P
    Eur J Pharmacol; 2003 Oct; 478(2-3):199-205. PubMed ID: 14575805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet.
    Deepa PR; Varalakshmi P
    Hum Exp Toxicol; 2003 May; 22(5):229-35. PubMed ID: 12774884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis.
    Kumar SA; Sudhahar V; Varalakshmi P
    Atherosclerosis; 2006 Nov; 189(1):115-22. PubMed ID: 16458314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
    Deepa PR; Varalakshmi P
    Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
    Deepa PR; Varalakshmi P
    Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin ameliorates glycemic index, lipid profile and enzymatic activities in serum, heart and liver tissues of rats fed with a combination of hypercaloric diet and chronic ethanol consumption.
    Chuffa LG; Fioruci-Fontanelli BA; Bordon JG; Pires RB; Braga CP; Seiva FR; Fernandes AA
    Indian J Biochem Biophys; 2014 Jun; 51(3):215-22. PubMed ID: 25204084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aspirin on atherogenic diet-induced diabetes mellitus.
    Sethi A; Parmar HS; Kumar A
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):371-7. PubMed ID: 21205219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia.
    Sudhahar V; Kumar SA; Sudharsan PT; Varalakshmi P
    Vascul Pharmacol; 2007 Jun; 46(6):412-8. PubMed ID: 17336164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of squalene on cyclophosphamide-induced toxicity.
    Senthilkumar S; Devaki T; Manohar BM; Babu MS
    Clin Chim Acta; 2006 Feb; 364(1-2):335-42. PubMed ID: 16150433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative.
    Kumar SA; Sudhahar V; Varalakshmi P
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):25-31. PubMed ID: 16737804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia.
    Kumar SA; Sudhahar V; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):197-204. PubMed ID: 15820496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrus peel polymethoxylated flavones extract modulates liver and heart function parameters in diet induced hypercholesterolemic rats.
    Green CO; Wheatley AO; McGrowder DA; Dilworth LL; Asemota HN
    Food Chem Toxicol; 2013 Jan; 51():306-9. PubMed ID: 23099503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental evaluation of the anti-atherogenic potential of the plant, Piper betle, and its active constitutent, eugenol, in rats fed an atherogenic diet.
    Venkadeswaran K; Thomas PA; Geraldine P
    Biomed Pharmacother; 2016 May; 80():276-288. PubMed ID: 27133067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.
    Abdali NT; Yaseen AH; Said E; Ibrahim TM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):409-422. PubMed ID: 28101628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.